Blood pressure management in metabolic syndrome

Yuichiro Yano, Satoshi Hoshide, Kazuyuki Shimada, Kazuomi Kario

Research output: Contribution to journalReview articlepeer-review


To assess 24-hour BP levels in subjects with metabolic syndrome is essential, because hypertension, which is the most prevalent component in the syndrome, makes the major contribution to cardiovascular risk. Because BP levels in subjects with metabolic syndrome are prone to be elevated in an out-of-office setting (i.e., nocturnal hypertension, morning hypertension), measurement of home and/or ambulatory BP levels is a promising method for managing the syndrome. The best treatment approach for this complex condition is a multifactorial one, much emphasis has been placed on RAAS inhibition, which is one of the most important factors in the disease, although there has been no clear evidence that RAAS inhibitors are more effective than other drugs for treatment of metabolic syndrome. However, previous trials for treating hypertension have generally enrolled non-obese patients, and have enrolled more complicated high-risk patients, in whom the most important issue is BP lowering itself here is thus a need to assess how to treat relatively younger subjects with-milder and/or high-normal hypertension, because the prevalence of such patients is expected to increase dramatically along with burgeoning obesity rates.

Original languageEnglish
Pages (from-to)214-226
Number of pages13
JournalCurrent Hypertension Reviews
Issue number3
StatePublished - 2008
Externally publishedYes


  • Masked hypertension
  • Metabolic syndrome
  • Morning hypertension
  • Prehypertension
  • Renin-angiotensin-aldosterone system


Dive into the research topics of 'Blood pressure management in metabolic syndrome'. Together they form a unique fingerprint.

Cite this